Research projects

Eros Di Giorgio Teamshot

Active Italy

Bowel cancer

Could ‘reprogramming’ bowel cancer cells make chemotherapy more effective?

This innovative Curestarter-funded research in Italy is exploring ways to make chemotherapy work better for people with bowel cancer, so fewer lives are cut short. 

Researcher: Dr Eros Di Giorgio

Could ‘reprogramming’ bowel cancer cells make chemotherapy more effective?
Federica Benevuti Team Shot

Active Italy

Lung cancer

Can studying the earliest stages of lung cancer lead to better treatments?

This exciting project in Italy, funded by you, is studying how cancer cells communicate to look for new ways to treat lung cancer. 

Researcher: Dr Federica Benvenuti

Can studying the earliest stages of lung cancer lead to better treatments?
David Sancho Headshot

Active Spain

General cancer research

Scouts and Soldiers – can we foster an immune interaction to kill cancer cells?

Curestarter researcher Dr Sancho in Spain is hoping to improve immunotherapy so it can be used to treat cancer more effectively for more patients. 

Researcher: Dr David Sancho

Scouts and Soldiers – can we foster an immune interaction to kill cancer cells?
Daniel Lietha Headshot

Active Spain

General cancer research

Could innovative AI technology revolutionise cancer treatment?

This pioneering research in Spain, co-funded with AECC, will use exciting AI technology to look for new cancer cures. Dr Lietha hopes this will lead to a whole new way to treat cancer. 

Researcher: Dr Daniel Lietha

Could innovative AI technology revolutionise cancer treatment?
Ruud Delwel Headshot

Active Netherlands

Leukaemia

Mission impossible: how can we target “Evi1” leukaemias?

Thanks to our Curestarters, Professor Delwel and his team in the Netherlands hope to find a much-needed new leukaemia cure. Acute Myeloid Leukaemia (AML) can sometimes be caused by a specific gene, so by better understanding this gene we can look for new cures. 

 

Researcher: Professor Ruud Delwel

Mission impossible: how can we target “Evi1” leukaemias?
Jurian Schuijers Headshot

Active Netherlands

Bowel cancer

Could targeting tiny droplets inside cells help to treat bowel cancer?

Dr Schuijers and his team in the Netherlands are using Curestarter funding to look for new bowel cancer cures. The team think that disrupting certain 'droplets' could be a powerful new way to stop cancer. 

Researcher: Dr Jurian Schuijers

Could targeting tiny droplets inside cells help to treat bowel cancer?
Silve Vicent Team Photo

Active Spain

Pancreatic cancer

Could combining therapies supercharge pancreatic cancer treatment?

Our project in Spain is exploring how to make pancreatic cancer treatments work better. Dr Vincent and his team are searching for a way to boost the effectiveness of a new treatment called KRAS inhibitors, so they can help more people.

Researcher: Dr Silvestre Vicent

Could combining therapies supercharge pancreatic cancer treatment?
Alvaro Teijeira Team Shot

Active Spain

General cancer research

Can sneaky signposts help blood vessels improve cancer immunotherapy?

This exciting research funded by Curestarters is looking boosting cancer treatments so they can help more patients. Dr Teijeira is developing a new kind of treatment to work alongside immunotherapies.

Researcher: Dr Alvaro Teijeira

Can sneaky signposts help blood vessels improve cancer immunotherapy?
Kenny Chi Kin Ip Team Shot

Active Australia

Brain cancer

Unlocking the origin: what is the role of neural cells in the development of childhood brain cancer?

Dr Ip in Australia is hoping to find new treatment targets for an aggressive form of childhood brain cancer. Thanks to our Curestarters this will help the quest for vital new cures. 

Researcher: Dr Kenny Chi Kin Ip

Unlocking the origin: what is the role of neural cells in the development of childhood brain cancer?
We have funded over £220m of research worldwide since 1979 and cancer survival rates have doubled in that time. 

But global funding for discovery research has declined in recent years and we risk losing the cancer cures of the future. Your support can turn the tide. 

Why is discovery research important?

  • 90,436
    Curestarters & counting have helped us fund...
  • 123
    projects in the last five years. But we have had to turn down…
  • 136
    other top ideas due to lack of funding. That's more than...
  • 50%
    of these potential new cancer cures lost.
  • 917
    people chose to become a Curestarter last month. Join them so that one day…
  • 0
    lives will be cut short by cancer.

Donate today to start new cures

Be part of the united effort to stop lives being cut short by cancer.